MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
285.87%
Quick Ratio
277.30%
Cash Ratio
72.20%
Debt to Asset Ratio
20.58%
Unit: Thousand (K) dollars
Assets Breakdown
Long-term marketable securities
Short-term marketable securities
Deferred tax assets, net
Others
Liabilities Breakdown
Additional paid-in capital
Treasury stock
Retained earnings
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
111,039
108,738
120,495
125,138
Short-term marketable securities
197,158
229,446
251,657
296,545
Trade receivables, net of allowances
76,920
39,072
59,786
69,629
Inventory
13,185
12,890
12,868
12,349
Prepaid expenses and other current assets
41,374
35,887
40,658
37,469
Total current assets
439,676
426,033
485,464
541,130
Strategic inventory
18,956
14,506
11,094
12,002
Operating lease right-of-use asset
6,860
7,196
4,583
4,776
Property and equipment, net
5,133
3,171
1,890
2,094
Long-term marketable securities
236,451
177,261
160,270
102,557
Other assets
2,946
5,153
5,153
8,049
Deferred tax assets, net
178,680
181,561
168,197
152,999
Total assets
888,702
814,881
836,651
823,607
Accounts payable
14,910
33,306
40,444
34,446
Accrued research and development expenses
21,628
34,091
33,954
28,322
Accrued and other liabilities
115,347
80,161
90,603
108,447
Short-term operating lease liability
1,917
1,627
1,084
1,050
Total current liabilities
153,802
149,185
166,085
172,265
Long-term operating lease liability
7,504
8,010
5,023
5,308
Long-term accrued government rebates
6,132
4,367
2,562
-
Long-term accrued income taxes
15,488
15,332
15,176
14,132
Total liabilities
182,926
176,894
188,846
191,705
Preferred stock
0
0
-
0
Common stock
142
141
140
139
Treasury stock
998,013
976,688
966,586
923,290
Additional paid-in capital
1,048,598
1,001,990
968,600
933,613
Accumulated other comprehensive income
436
918
2,264
2,341
Retained earnings
654,613
611,626
643,387
619,099
Total stockholders equity
705,776
637,987
647,805
631,902
Total liabilities and stockholders equity
888,702
814,881
836,651
823,607
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Short-term marketable
securities
$197,158K
(-17.67%↓ Y/Y)
Cash and cash
equivalents
$111,039K
(8.07%↑ Y/Y)
Trade receivables,
net of allowances
$76,920K
(19.13%↑ Y/Y)
Prepaid expenses and
other current assets
$41,374K
(72.08%↑ Y/Y)
Inventory
$13,185K
(7.40%↑ Y/Y)
Total current assets
$439,676K
(-0.78%↓ Y/Y)
Long-term marketable
securities
$236,451K
(36.85%↑ Y/Y)
Deferred tax assets, net
$178,680K
(10.14%↑ Y/Y)
Strategic inventory
$18,956K
(137.22%↑ Y/Y)
Operating lease
right-of-use asset
$6,860K
(38.20%↑ Y/Y)
Property and equipment,
net
$5,133K
(118.61%↑ Y/Y)
Other assets
$2,946K
(-64.52%↓ Y/Y)
Total assets
$888,702K
(10.85%↑ Y/Y)
Total liabilities and
stockholders equity
$888,702K
(10.85%↑ Y/Y)
Total stockholders
equity
$705,776K
(11.01%↑ Y/Y)
Total liabilities
$182,926K
(10.24%↑ Y/Y)
Treasury stock
$998,013K
(15.12%↑ Y/Y)
Additional paid-in capital
$1,048,598K
(16.40%↑ Y/Y)
Total current
liabilities
$153,802K
(6.32%↑ Y/Y)
Long-term accrued income
taxes
$15,488K
(-1.21%↓ Y/Y)
Long-term operating lease
liability
$7,504K
(34.29%↑ Y/Y)
Long-term accrued
government rebates
$6,132K
Retained earnings
$654,613K
(9.21%↑ Y/Y)
Accumulated other
comprehensive income
$436K
(-80.97%↓ Y/Y)
Common stock
$142K
(2.90%↑ Y/Y)
Accrued and other
liabilities
$115,347K
(26.65%↑ Y/Y)
Accrued research and
development expenses
$21,628K
(-25.55%↓ Y/Y)
Accounts payable
$14,910K
(-36.62%↓ Y/Y)
Short-term operating lease
liability
$1,917K
(88.50%↑ Y/Y)
Buy us a coffee
CORCEPT THERAPEUTICS INC (CORT)
CORCEPT THERAPEUTICS INC (CORT)